Endometriosis causes infertility through multiple overlapping mechanisms, from physical blockages in the reproductive tract to invisible chemical changes that poison the environment around eggs, sperm, and embryos. Women with infertility are about 2.5 times more likely to have endometriosis than women without fertility problems, and the condition doesn’t need to be severe to interfere with conception.
What makes endometriosis particularly frustrating is that no single mechanism explains every case. Some women have obvious structural damage visible during surgery. Others have a pelvis that looks relatively normal but is flooded with inflammatory molecules that quietly sabotage fertility at every stage, from ovulation to implantation. Here’s how each of those pathways works.
Scar Tissue and Structural Damage
Endometriosis tissue growing outside the uterus triggers a chronic wound-healing response. The surrounding tissue becomes irritated and forms scar tissue, along with bands of fibrous tissue called adhesions that cause pelvic organs to stick to each other. Over time, these adhesions can warp the normal anatomy of the reproductive tract.
The fallopian tubes are especially vulnerable. They need to move freely to catch an egg after ovulation, and delicate finger-like projections called fimbria at the end of each tube must sweep the egg inward. Adhesions can pin the tubes in place, kink them, or damage the fimbria so they can no longer pick up eggs. In some cases, endometriosis blocks the tube entirely, preventing sperm and egg from ever meeting. This is the most straightforward way the disease causes infertility, and it’s the mechanism most people picture first, but it’s far from the only one.
A Toxic Inflammatory Environment
Even when the tubes and ovaries are structurally intact, the pelvic environment in women with endometriosis is chemically hostile to reproduction. The fluid that naturally bathes the pelvic organs becomes loaded with inflammatory signaling molecules produced by activated immune cells. These molecules, particularly one called IL-6, are significantly elevated in women with endometriosis compared to women without the disease.
This inflammatory soup damages fertility in several ways at once. Activated immune cells in the pelvic fluid ramp up their consumption of sperm, literally engulfing and destroying them before they can reach the egg. Research in Human Reproduction found that high concentrations of inflammatory molecules in this fluid are directly toxic to embryos, with IL-6 showing the strongest correlation with embryo damage. The effect is dose-dependent: the more inflammation, the worse the toxicity.
Perhaps most striking, a specific protein found in the pelvic fluid of endometriosis patients interferes with the ability of sperm to bind to the outer shell of the egg. When sperm were exposed to fluid from endometriosis patients, binding dropped by more than 60% compared to controls. This inhibitory effect was stronger in endometriosis than in other fertility conditions, and it wasn’t caused by changes in sperm movement or survival. The sperm looked fine but simply couldn’t latch on.
The Uterine Lining Resists Pregnancy
For pregnancy to occur, a fertilized embryo must implant in the uterine lining during a brief window of receptivity. Progesterone is the hormone responsible for transforming the lining into a welcoming environment for an embryo, triggering the stromal cells to mature into specialized cells that support early pregnancy. In women with endometriosis, this process frequently fails.
The problem is called progesterone resistance. The uterine lining either produces fewer progesterone receptors or stops responding to progesterone effectively. When progesterone can’t do its job, the lining doesn’t mature properly. Estrogen’s growth-promoting effects go unchecked, inflammation increases, and the tissue never reaches the state needed for an embryo to implant. Genes critical to receptivity, particularly one called HOXA10 that helps regulate implantation, become underexpressed. The net result is a uterus that looks normal on imaging but is functionally inhospitable to a developing embryo.
This mechanism helps explain why many women with endometriosis experience recurrent implantation failure during IVF, even when healthy-looking embryos are transferred.
Damage to Ovarian Reserve
Endometriomas, the blood-filled ovarian cysts that form in many women with endometriosis, pose a direct threat to the egg supply. A prospective study tracking women over time found that those with endometriomas had a median AMH level (a blood marker reflecting the remaining pool of eggs) of 2.83 ng/mL, compared to 4.42 ng/mL in healthy women. More concerning, the rate of decline was dramatically faster: women with endometriomas lost a median of 26.4% of their AMH over the study period, versus just 7.4% in the control group.
This accelerated loss happens because the cyst itself creates a toxic local environment within the ovary. The old blood trapped inside generates oxidative stress and inflammatory damage that destroys surrounding follicles, the tiny structures that house immature eggs. Surgery to remove endometriomas can provide symptom relief but also risks removing healthy ovarian tissue along with the cyst, potentially reducing egg supply further. This creates a difficult clinical trade-off that your fertility specialist will weigh based on cyst size, symptoms, and your timeline for pregnancy.
Hormonal Disruption of Ovulation
Endometriosis is associated with luteal phase deficiency, a condition in which the second half of the menstrual cycle is too short or produces too little progesterone to sustain an early pregnancy. The mechanism starts earlier in the cycle than you might expect. Abnormal signaling from the brain to the ovaries during the first half of the cycle, specifically disrupted pulses of the hormones that trigger follicle growth, leads to poor follicle development. A poorly developed follicle produces a weak corpus luteum after ovulation, which in turn secretes insufficient progesterone and estrogen during the luteal phase.
The result is a compressed window for implantation, inadequate hormonal support for the uterine lining, and a higher likelihood that even a successfully fertilized egg will fail to establish a pregnancy.
Why Severity Doesn’t Always Predict Fertility
One of the most confusing aspects of endometriosis is that the stage of disease doesn’t reliably predict whether you’ll struggle to conceive. Some women with minimal visible endometriosis are profoundly infertile, while others with extensive disease conceive without difficulty. This disconnect exists because the inflammatory, hormonal, and molecular mechanisms described above operate independently of how much visible tissue is present.
To address this gap, fertility specialists developed the Endometriosis Fertility Index (EFI), a scoring system validated on over 800 patients that combines your age, how long you’ve been trying to conceive, your pregnancy history, and a surgical assessment of how well each tube, fimbria, and ovary actually functions after treatment. Unlike the older staging system that simply tallied up disease severity, the EFI predicts your actual likelihood of conceiving after surgery. It’s one of the few tools that reliably connects surgical findings to real-world pregnancy outcomes, and it can help guide decisions about whether to try naturally after surgery or move directly to assisted reproduction.
How These Mechanisms Overlap
In most women with endometriosis-related infertility, several of these pathways are active simultaneously. A woman might have mildly distorted tubes that still allow eggs through, but the inflammatory pelvic fluid impairs sperm binding, the uterine lining resists implantation due to progesterone resistance, and her ovarian reserve is declining faster than expected. No single factor is severe enough to fully explain the infertility on its own, but together they reduce the probability of conception at every step from ovulation to implantation.
This is why treatment often needs to address multiple barriers. Surgery can remove adhesions and restore anatomy, but it won’t fix progesterone resistance or reverse inflammatory changes in the pelvic fluid. IVF bypasses the tubes and the hostile pelvic environment entirely, which is why it’s often effective for endometriosis patients, though implantation challenges may still persist. Understanding which mechanisms are most relevant in your case is what allows your care team to choose the approach most likely to work.